Table 3.
Analysis of covariance of endline HbA1c of the intervention and control groupsa
| Group | HbA1c baseline (95% CI) | HbA1c endline (95% CI) | Estimated effect size (CI) | F | P-value |
|---|---|---|---|---|---|
| Intervention | 6.84 (6.40 to 7.27) | 6.26 (6.19 to 6.33) | −0.74 (−1.32 to −0.02) | 12.92 | 0.015b |
| Control | 6.36 (5.99 to 6.73) | 6.82 (6.69 to 6.95) |
Dependent variable: HbA1c endline. (HbA1c = glycosylated haemoglobin).
The endline HbA1c was compared between the treatment groups adjusting for baseline HbA1c using ANCOVA.